Conference Opening and Welcome

Novel Non-Viral Vector Based CAR-T Platform Development and Progress Update

• Application of Sendai Virus Vector to Cell Engineering and Gene Therapy

ID Pharma Co., Ltd. Case Study - Sendai Virus

• Current Weakness in the Technology Landscape

Overview of the Sumitomo Dainippon Manufacturing Plant for Regenerative Medicine & Cell Therapy - SMaRT

11:30 - 12:30